Clik here to view.
MassDevice.com +5 | The top 5 medtech stories for November 22, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Baxter touts blood purification efficiency in EBP studies
Baxter (NYSE:BAX) today released data from 2 studies on extracorporeal blood purification studies, touting the blood purification method’s ability to remove harmful molecules linked to inflammation....
View ArticleClik here to view.
French biomed incubator Clinatec raises €10m
French biomedical research center Clinatec said today that it has raised $10.6 million (€10 million) to support research for diagnosis and treatment of neurodegenerative diseases, cancer and motor...
View ArticleClik here to view.
Immunovaccine’s targeted ovarian cancer therapy wins orphan drug status in EU
Immunovaccine Inc. said today that the European Medicines Agency granted orphan drug designation for its immunotherapy candidate for ovarian cancer in the E.U. Orphan drug designation is granted to...
View ArticleClik here to view.
Helius Medical extends U.S. Army contract, looks to future of portable neuromod
Helius Medical Technologies said this week it expanded a source cost sharing contract with the U.S. Army Medical Research and Materiel Command, while its CEO Phil Deschamps is looking to the future of...
View ArticleClik here to view.
French Competent Authority provides roadmap for manufacturers as European...
By Stewart Eisenhart, Emergo Group Medical device regulators in France have published new information for manufacturers on how to adjust to an expected decline in Notified Bodies in Europe due to more...
View ArticleClik here to view.
Neovasc dodges investor lawsuit over $70m loss to CardiAQ Valve
Neovasc (NSDQ:NVCN) yesterday dodged an investor lawsuit brought in the wake of its $70 million loss to replacement mitral valve rival and Edwards Lifesciences (NYSE:EW) subsidiary CardiAQ Valve. A...
View ArticleClik here to view.
Allergan expands neurological portfolio with $125m Chase Pharmaceuticals buy
Allergan (NYSE:AGN) said today that it acquired Chase Pharmaceuticals for an upfront payment of $125 million, expanding the Dublin-based company’s neurological portfolio. Washington, D.C.-based Chase...
View ArticleClik here to view.
Supersonic spray produces nanomaterials for wearable electronics
Researchers from the University of Illinois at Chicago and Korea University have developed an ultrathin, highly conductive nanomaterial produced by a supersonic spray, according to the study published...
View ArticleClik here to view.
Appeals court overturns Stryker’s $9m win over insurer in Duracon Uni-Knee...
A federal appeals court last week overturned a $9 million win for Stryker (NYSE:SYK) over TIG Insurance. Stryker, which acquired the Duracon Uni-Knee with its $1.9 billion buyout of Howmedica from...
View ArticleClik here to view.
Xtant Medical wins FDA nod for Xsert lumbar implant
Xtant Medical (NYSE:XTNT) said today that it won 510(k) clearance from the FDA for its Xsert lumbar expandable interbody spine implant. The device is designed for lumbar fusion at 1 or 2 levels and is...
View ArticleClik here to view.
Zimmer Biomet joins Indo UK Institute of Health’s Medicity program
Zimmer Biomet (NYSE:ZBH) said today that it inked a 20-year collaboration with the Indo UK Institute of Health as a preferred orthopedic partner for the Medicity program. The partnership aims to...
View ArticleClik here to view.
Array of implanted electrodes stimulates nerve cells in spinal cord injuries
Researchers from the Oregon State University College of Engineering and the University of Utah demonstrated how patients with spinal cord injuries could regain use of paralyzed limbs using a tiny array...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for November 23, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Micell begins MiStent clinical trial in Japan
Micell Technologies said today that it began its Dessolve J randomized, double-blind study comparing its MiStent SES sirolimus eluting absorbable polymer coronary stent to the Xience V everolimus...
View ArticleClik here to view.
Windtree touts inhaled therapy for infants with respiratory distress syndrome
Windtree Therapeutics (NSDQ:WINT) today released data from a phase IIa trial evaluating its inhaled Aerosurf lucinactant designed for premature infants with respiratory distress syndrome. Results from...
View ArticleClik here to view.
Oramed touts phase Ib data for type 2 diabetes capsule
Oramed Pharmaceuticals (NSDQ:ORMP) said today that it finished a phase Ib study of its oral GLP-1 analog capsule for type 2 diabetes. Glucagon-like peptide-1 (GLP-1) is a hormone that stimulates the...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for November 29, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
NeuroMetrix wins CE Mark for Quell wearable pain relief device
NeuroMetrix (NSDQ:NURO) said today it won CE Mark approval in the European Union for its Quell wearable pain relief device, now cleared as a class IIa medical device in the region. The Waltham,...
View ArticleClik here to view.
Philips launches Intellispace Portal 9.0 radiological visual analysis &...
Royal Philips (NYSE:PHG) said today it launched its IntelliSpace Portal 9.0, the most recent iteration of its radiological visual analysis and quantification platform. The new version of the platform...
View Article
